SI
Sofinnova Investments Portfolio holdings
AUM
$2.32B
1-Year Est. Return
101.65%
This Fund
S&P 500
1 Year Est. Return
+101.65%
AUM
$1.63B
AUM Growth
+$160M
(+11%)
Holding
67
Top Buys
| 1 | +$49.3M | |
| 2 | +$40.1M | |
| 3 | +$33.8M | |
| 4 |
Glaukos
GKOS
|
+$28.7M |
| 5 |
United Therapeutics
UTHR
|
+$24.3M |
Top Sells
| 1 | +$75.6M | |
| 2 | +$31.5M | |
| 3 | +$29.6M | |
| 4 |
uniQure
QURE
|
+$25.8M |
| 5 |
Insmed
INSM
|
+$25.7M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Disc Medicine
IRON
$2.53B
| $896K | 0.05% |
13,553
+6,241
|
|
||
52
Bolt Biotherapeutics
BOLT
$8.18M
| $733K | 0.04% |
137,721
|
|
||
53
Acadia Pharmaceuticals
ACAD
$3.84B
| $572K | 0.04% |
+26,800
|
|
||
54
Establishment Labs
ESTA
$1.95B
| $442K | 0.03% |
10,787
-17,333
|
|
||
|
IMA
55
ImageneBio Inc
IMA
$67.9M
| $260K | 0.02% |
31,884
-1
|
|
||
|
YMAB
56
DELISTED
Y-mAbs Therapeutics
YMAB
| – | – |
-2,194,278
|
|
||
|
MTSR
57
DELISTED
Metsera Inc
MTSR
| – | – |
-36,191
|
|
||
58
Structure Therapeutics
GPCR
$4.12B
| – | – |
-34,353
|
|
||
59
iShares Biotechnology ETF
IBB
$8.54B
| – | – |
0
|
|
||
|
INZY
60
DELISTED
Inozyme Pharma
INZY
| – | – |
-4,280,308
|
|
||
61
iShares Russell 2000 ETF
IWM
$71.3B
| – | – |
0
|
|
||
62
Eli Lilly
LLY
$894B
| – | – |
-97,018
|
|
||
63
Liquidia Corp
LQDA
$3.38B
| – | – |
0
|
|
||
64
Replimune Group
REPL
$680M
| – | – |
-1,806,529
|
|
||
65
Summit Therapeutics
SMMT
$12.7B
| – | – |
0
|
|
||
66
Syndax Pharmaceuticals
SNDX
$2.13B
| – | – |
-1,524,440
|
|
||
67
State Street SPDR S&P Biotech ETF
XBI
$8.09B
| – | – |
0
|
|